QPS-50, which induces LTD in healthy subjects, was administered for 12 weeks in four patients with intractable epilepsy. Epileptic symptoms worsened in two patients, probably because of abnormal inhibitory control of the cortex. The possibility of clinical aggravation should be seriously considered when treating intractable epilepsy patients with non-invasive stimulation methods.